These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 200708)

  • 21. Distinctive characteristics of crude interferon from virus-infected guinea-pig embryo fibroblasts.
    Winship TR; Fong CK; Hsiung GD
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():843-7. PubMed ID: 6323627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory state of cells to interferon induction.
    Rousset S
    J Gen Virol; 1974 Jan; 22(1):9-20. PubMed ID: 4360396
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth of Newcastle disease and herpes virus and interferon production in a monkey-mouse hybrid line.
    Coppey J
    J Gen Virol; 1972 Jan; 14(1):9-14. PubMed ID: 4334778
    [No Abstract]   [Full Text] [Related]  

  • 24. Activity of mouse interferon in human cells.
    Bodo G; Palese P; Lindner J
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1392-5. PubMed ID: 4333098
    [No Abstract]   [Full Text] [Related]  

  • 25. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 26. Interferon induction and action in transformed poikilothermic cells.
    Vassileva V; Galabov A
    Acta Microbiol Acad Sci Hung; 1975; 22(3):323-8. PubMed ID: 168742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study on the anticellular and antiviral effects of interferon and the haemopoietic stem cell inhibition factor.
    Orlova TG; Golovanova TA; Shcheglovitova ON; Mysyakin EB; Bokhonko AI; Kaulen DR
    Acta Virol; 1979 May; 23(3):177-82. PubMed ID: 41429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights.
    Smith TJ; Wagner RR
    J Exp Med; 1967 Apr; 125(4):579-93. PubMed ID: 6066967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulating effect of mouse sarcoma virus on the multiplication of Newcastle disease virus.
    Peries J; Canivet M; Olivie M; Boiron M
    J Gen Virol; 1972 Feb; 14(2):207-8. PubMed ID: 4334783
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells.
    Desmyter J; Stewart WE
    Virology; 1976 Apr; 70(2):451-8. PubMed ID: 178096
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels.
    Weber JM; Stewart RB
    J Gen Virol; 1975 Sep; 28(3):363-72. PubMed ID: 170377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and histochemical studies on cultures of mouse peritoneal leucocytes during interferon formation.
    Khesin YE; Voronina FV; Amchenkova AM
    Acta Virol; 1970 Nov; 14(6):445-52. PubMed ID: 4099770
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of macrophage migration by virus-induced interferon preparations.
    Imanishi J
    Jpn J Microbiol; 1975 Oct; 19(5):337-42. PubMed ID: 1241396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production of inhibitors of interferon action by cell lines sensitive and insensitive to the antiviral action of interferon].
    Khesin IaE; Parfenov VV; Amchenkova AM; Narovlianskiĭ AN; Tkach TA
    Vopr Virusol; 1985; 30(5):584-6. PubMed ID: 2416134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterospecific activity of rat interferon.
    Lobodzińska M; Mejbaum-Katzenellenbogen W; Biernacka I; Zamorska B; Albin M; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):493-7. PubMed ID: 219806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
    Overall JC; Yeh TJ; Kern ER
    J Interferon Res; 1984; 4(4):529-33. PubMed ID: 6094683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renaturation of inactivated interferons: requirement for reduction of a major component; lack of requirement for reduction of a minor component.
    Stewart WE; De Somer P; De Clercq E
    J Gen Virol; 1974 Sep; 24(3):567-70. PubMed ID: 4372304
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions.
    Fuchsberger N; Hajnická V; Boreckyý L
    Acta Virol; 1975 Jan; 19(1):59-66. PubMed ID: 235199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative insensitivity of spleen cells to interferon.
    Gifford GE
    J Immunol; 1974 Dec; 113(6):1947-51. PubMed ID: 4372271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.